Best neurologists: TOP 478 doctors

Pediatric Neurologist with expertise in epilepsy, headache, sleeping disorders, child neurology and development monitoring. Completed medical degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2006 and a child neurology minor assistant training from Istanbul Medipol University in 2017. Completed specialist doctor training from Şanlıurfa Suruç State Hospital in 2012 and Istanbul Gaziosmanpaşa Training and Research Hospital in 2017. Holds various certifications including Denver 2 Developmental Screening Test qualification, Neotonal Resuscitation Program practitioner certification and various courses in child neurology, epilepsy, neuroimmunology, EMG and basic genetics. Member of Turkey Child Neurology Society.

With more than 120 medical publications on stem cells in preeminent medical journals, Professor Yvan Torrente is considered one of the world’s best scientists in regenerative medicine, genetic engineering of stem cells and advanced gene therapies for degenerative diseases. Prof. Torrente is currently the director of the Neurology department of the “Policlinico” Hospital in Milan as well as the head of the cell laboratory for the advanced therapy medical products in Milan.

In addition, Yvan is a professor in neurology at the University of Milan. Prof. Torrente is assisted by a team of highly trained and well-regarded doctors, biologists and researchers in the laboratory in Milan who provide external assistance and consultancy to our medical team. Specifically, over the years, Professor Torrente has helped our team to develop GMP compliant and high-quality safety standards in complex research projects, applying the same to medicinal and clinical products catered for specific uses.

Professor Torrente is currently leading and supervising several clinical trials in Europe on stem cell use in human beings as well as other advanced therapy medical products. He also provides assistance and consultancy services to several other hospitals worldwide, especially in the U.S., Canada and the U.K. Finally, Yvan is a well-known speaker at prestigious events, seminars and symposiums worldwide.

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21